Company Description
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States.
Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.
The company enables clinicians to access its applications through mobile devices, such as smartphones.
It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
| Country | United States |
| Founded | 2013 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,430 |
| CEO | Emmanuel Krakaris |
Contact Details
Address: 111 Sutter Street, Suite 1300 San Francisco, California 94104 United States | |
| Phone | 561-989-2208 |
| Website | augmedix.com |
Stock Details
| Ticker Symbol | AUGX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001769804 |
| CUSIP Number | 05105P107 |
| ISIN Number | US05105P1075 |
| Employer ID | 83-3299164 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Emmanuel Krakaris | President, Chief Executive Officer, Secretary and Director |
| Ian Shakil | Founder, Chief Strategy Officer and Director |
| Sandra Breber | Chief Operating Officer |
| Saurav Chatterjee Ph.D. | Chief Technology Officer |
| Paul Louis Ginocchio | Chief Financial Officer |
| Todd Holvick | Head of Legal and Compliance |
| Lia Wallick | Head of People |
| Dr. Davin Lundquist M.D. | Chief Medical Officer |
| Jonathan Hawkins | Chief Revenue Officer |
| Tomer Levy | Senior Vice President of Engineering |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 19, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jul 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 19, 2024 | 8-K | Current Report |
| Jun 26, 2024 | 8-K | Current Report |
| Jun 25, 2024 | 8-K/A | [Amend] Current report |
| Jun 25, 2024 | 8-K | Current Report |